SRPT:NASDAQ
Sarepta Therapeutics Inc
$17.95
arrow_downward
-1.43%(-0.26) 1D
Oct 9, 2:24:12 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SRPT...
Open
$18.24
High
$18.52
Low
$17.83
Mkt. cap
1.90B
Avg. vol.
3.09M
Volume
1.05M
52-wk high
$24.68
52-wk low
$14.69
EPS
-$1.66
Beta
0.38
Shares outstanding
105.63M
No. of employees
835
Open
$18.24
High
$18.52
Low
$17.83
Mkt. cap
1.90B
Avg. vol.
3.09M
Volume
1.05M
52-wk high
$24.68
52-wk low
$14.69
EPS
-$1.66
Beta
0.38
Shares outstanding
105.63M
No. of employees
835
News stories
From web sources and news partners
Simply Wall Street
·
6 hours ago
How Investors May Respond To Sarepta Therapeutics (SRPT) Wider ELEVIDYS Benefit Data
Stock Traders Daily
·
7 hours ago
(SRPT) Risk Channels and Responsive Allocation
GuruFocus
·
1 day ago
SRPT Maintained by RBC Capital -- Price Target Lowered to $17.00
https://www.dars.gov.et/
·
1 month ago
Sarepta Therapeutics (SRPT) Edges Higher to $21.33 as Shares Hold Above Key Support - PCR Spike
Profile
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia
About Sarepta Therapeutics Inc